252 related articles for article (PubMed ID: 32643099)
1. Medulloblastoma: an Old Diagnosis with New Promises.
Szalontay L; Khakoo Y
Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
[TBL] [Abstract][Full Text] [Related]
2. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O; Győrffy B
Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
[TBL] [Abstract][Full Text] [Related]
3. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
4. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
7. New Approaches in Targeted Therapy for Medulloblastoma in Children.
Maier H; Dalianis T; Kostopoulou ON
Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of the management of pediatric and adult medulloblastoma].
Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma: From Myth to Molecular.
Ramaswamy V; Taylor MD
J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
[TBL] [Abstract][Full Text] [Related]
10. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
11. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
12. SEOM clinical guideline for management of adult medulloblastoma (2020).
Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in Older Adults: A Case Report and Literature Review.
Murase M; Saito K; Abiko T; Yoshida K; Tomita H
World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
[TBL] [Abstract][Full Text] [Related]
14. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
[TBL] [Abstract][Full Text] [Related]
15. How we treat medulloblastoma in adults.
Franceschi E; Seidel C; Sahm F; Pajtler KW; Hau P
ESMO Open; 2021 Aug; 6(4):100173. PubMed ID: 34118771
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
17. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups.
Eid AM; Heabah NAE
J Egypt Natl Canc Inst; 2021 Feb; 33(1):6. PubMed ID: 33555447
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]